Vanda Pharmaceuticals(VNDA) - 2025 Q4 - Earnings Call Transcript

Vanda Pharmaceuticals (NasdaqGM:VNDA) Q4 2025 Earnings call February 11, 2026 04:30 PM ET Company ParticipantsAndrew Tsai - Managing DirectorKevin Moran - CFOMihael Polymeropoulos - CEORaghuram Selvaraju - Managing DirectorConference Call ParticipantsMadison El-Saadi - Healthcare Research AnalystNone - AnalystOperatorThank you for standing by. My name is Jordan, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Q4 2025 Vanda Pharmaceuticals Inc. earnings conferenc ...